Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

BioXcel Therapeutics (BTAI) Stock Is Extremely Volatile Today: What's Going On?

Sonnet BioTherapeutics Inc.

Shares of BioXcel Therapeutics Inc (NASDAQ:BTAI) are trading higher Tuesday morning, reversing sharply following earlier weakness, after the company announced its financial results for the second quarter. Here’s what investors need to know.

What To Know: The biopharmaceutical firm reported a net loss of $19.2 million, or a loss of $2.45 per share, for the quarter ended June 30. This marks a wider loss compared to the $8.3 million net loss recorded in the same period of the previous year.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.